60

Guangzhou Kingmed Diagnostics Group Co LtdSHG 603882 Stock Report

Last reporting period 30 Sep, 2023

Updated 22 Oct, 2024

Last price

Market cap $B

1.912

Small

Exchange

XSHG - Shanghai Stock Exchange

603882.SS Stock Analysis

60

Neutral

Based on Eyestock quantitative analysis, 603882.SS`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

71/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

73.0 %

Undervalued

Market cap $B

1.912

Dividend yield

2.88 %

Shares outstanding

467.3 B

Guangzhou Kingmed Diagnostics Group Co., Ltd. engages in the provision of outsourced medical examination and pathological diagnosis services to medical institutions. The company is headquartered in Guangzhou, Guangdong and currently employs 12,371 full-time employees. The company went IPO on 2017-09-08. The firm is also engaged in other businesses, including sales of diagnostic products, provision of physical examination and cold chain logistics services.

View Section: Eyestock Rating